Panel Decentralized & Hybrid track
Decentralized Clinical Trial Elements to Improve Participant Access and Representation
Wed, Feb 5, 2025 · 9:15–9:55 AM EST Rosen Shingle Creek
About this session
Panel Discussion.
The potential for decentralized or hybrid clinical trials to mitigate disparities has received much attention, but are DCTs/hybrid trial populations actually more representative than those of traditional site-based trials? With increased emphasis on diversity in registrational clinical trials, can the use of DCT elements serve as one strategy to effect change? This panel discussion will explore opportunities and challenges in deploying DCT solutions to promote more representative clinical trials.
Speakers
-
Decentralized Clinical Trial (DCT) Strategy Development Lead · Bayer Healthcare
Panelist